Drugs Made In America Acquisition II Corp. logo

Drugs Made In America Acquisition II Corp. (DMII)

Market Open
26 Oct, 06:56 PM
NASDAQ (NMS) NASDAQ (NMS)
$
10. 19
0
0%
$
649.1M Market Cap
- P/E Ratio
- Div Yield
187,538 Volume
- Eps
$ 10.19
Previous Close
Add Transaction
Day Range
10.19 10.2
Year Range
9.86 10.33
Want to track DMII and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Drugs Made In America Acquisition II Corp. Investors

Name Quantity Cost Value Profit ($) Gain (%)
IH
Isaac Haas Hbk Investments LP
500,000 $4.95M $5.09M $140,000 2.83%
DS
Danny Salinas Cantor Fitzgerald LP
363,100 $3.65M $3.7M $43,572 1.19%
Daniel L. Lippincott
Daniel L. Lippincott Karpus Management Inc.
2.79M $27.81M $28.41M $596,253.07 2.14%
DB
David Barlow Glazer Capital LLC
2.35M $23.26M $23.97M $704,928.3 3.03%
MB
Mitchel Bialek Css LLC/IL
110,042 $1.09M $1.12M $31,912.18 2.93%
SK
Steven Katznelson Radcliffe Capital Management LP
575,721 $5.7M $5.86M $161,194.19 2.83%
JC
Jay Coppoletta PEAK6 LLC
100,000 $990,000 $1.02M $28,000 2.83%
CW
CaSaundra Wu Westchester Capital Management LLC
500,006 $4.95M $5.1M $147,500.29 2.98%
MH
Matthew Herman Logan Stone Capital LLC
11,313 $112,790.61 $115,166.34 $2,375.73 2.11%
BO
Brian Oliveira Clear Street Group Inc.
224,879 $2.26M $2.29M $31,689.21 1.4%
Mercuria Capital Strategies LLC
Mercuria Capital Strategies LLC Mercuria Capital Strategies LLC
750,000 $7.48M $7.63M $157,500 2.11%
ABC Arbitrage SA
ABC Arbitrage SA ABC Arbitrage SA
35,000 $346,500 $356,650 $10,150 2.93%
Mikhail Shilshtut
Mikhail Shilshtut Limestone Investment Advisors LP
151,000 $1.52M $1.54M $19,191 1.26%